Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Aug;118(7):1639–1644. doi: 10.1111/j.1476-5381.1996.tb15586.x

Action of probucol in arteries from normal and hypercholesterolaemic rabbits.

M Del Rio 1, T Chulia 1, E Ruiz 1, T Tejerina 1
PMCID: PMC1909827  PMID: 8842426

Abstract

1. The effect of probucol on the vascular reactivity of different arteries isolated from rabbits was studied as well as its effects on the development of atherosclerosis in a cholesterol-fed rabbit model. 2. Probucol 10(-6)-5 x 10(-4)M produced a concentration-dependent inhibition of the contractile responses induced by KCI (80 mM), the sequence for the IC50 was: mesenteric artery (5th branch, 4.8 +/- 2.6 x 10(-5) M) > aorta (8.2 +/- 2.3 x 10(-5) M) > femoral artery (> 5 x 10(-4) M). The response to noradrenaline was: mesenteric artery (5th branch, 4.2 +/- 1.3 x 10(-5) M) > aorta (3.2 +/- 3.0 x 10(-4) M) > femoral (> 5 x 10(-4) M). 3. In the aorta, probucol (10(-5)-10(-4) M) shifted the concentration-response curves to Ca2+ downward and to the right. 4. Probucol at 5 x 10(-5) M and 5 x 10(-4) M showed a reduction in the 45Ca2+ uptake in resting, non-stimulated aortic rings as well as the uptake induced by both noradrenaline 10(-6) M and KCI 80 mM. 5. In experiments in vivo, probucol did not affect lipid profiles; however, drug-treatment significantly decreased the cholesterol content of aortic tissue and the extent of intimal surface covered with atherosclerotic lesions. 6. The vascular reactivity was recovered in femoral arteries from rabbits on the atherogenic diet plus probucol. 7. It is concluded that the effect of probucol in vascular smooth muscle can be attributed to an inhibition of Ca2+ entry through both potential- and receptor-operated pathways. Moreover our findings suggest that the effects of probucol on movement of calcium in vascular smooth muscle may play an important role in the mechanism of antiatherogenic properties of this drug.

Full text

PDF
1639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdalla S., Zarga M. A., Afifi F., al-Khalil S., Mahasneh A., Sabri S. Effects of 3,3'-di-O-methylquercetin on guinea-pig isolated smooth muscle. J Pharm Pharmacol. 1989 Feb;41(2):138–141. doi: 10.1111/j.2042-7158.1989.tb06413.x. [DOI] [PubMed] [Google Scholar]
  2. Atkinson J. Vascular calcium overload. Physiological and pharmacological consequences. Drugs. 1992;44 (Suppl 1):111–118. doi: 10.2165/00003495-199200441-00021. [DOI] [PubMed] [Google Scholar]
  3. Barrigon S., Tejerina T., Delgado C., Tamargo J. Effects of chlorbutol on 45Ca movements and contractile responses of rat aorta and its relevance to the actions of Syntocinon. J Pharm Pharmacol. 1984 Aug;36(8):521–526. doi: 10.1111/j.2042-7158.1984.tb04443.x. [DOI] [PubMed] [Google Scholar]
  4. Blumlein S. L., Sievers R., Kidd P., Parmley W. W. Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit. Am J Cardiol. 1984 Oct 1;54(7):884–889. doi: 10.1016/s0002-9149(84)80226-x. [DOI] [PubMed] [Google Scholar]
  5. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  6. Cauvin C., Loutzenhiser R., Van Breemen C. Mechanisms of calcium antagonist-induced vasodilation. Annu Rev Pharmacol Toxicol. 1983;23:373–396. doi: 10.1146/annurev.pa.23.040183.002105. [DOI] [PubMed] [Google Scholar]
  7. Cauvin C., Tejerina M., van Breemen C. Effects of atriopeptin III on isolated mesenteric resistance vessels from SHR and WKY. Am J Physiol. 1987 Dec;253(6 Pt 2):H1612–H1617. doi: 10.1152/ajpheart.1987.253.6.H1612. [DOI] [PubMed] [Google Scholar]
  8. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daugherty A., Zweifel B. S., Schonfeld G. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br J Pharmacol. 1989 Oct;98(2):612–618. doi: 10.1111/j.1476-5381.1989.tb12635.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ginsburg R., Davis K., Bristow M. R., McKennett K., Kodsi S. R., Billingham M. E., Schroeder J. S. Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits. Lab Invest. 1983 Aug;49(2):154–158. [PubMed] [Google Scholar]
  11. Godfraind T., Kaba A. Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle. Br J Pharmacol. 1969 Jul;36(3):549–560. doi: 10.1111/j.1476-5381.1969.tb08010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heistad D. D., Armstrong M. L., Marcus M. L., Piegors D. J., Mark A. L. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984 Jun;54(6):711–718. doi: 10.1161/01.res.54.6.711. [DOI] [PubMed] [Google Scholar]
  13. Hudgins P. M., Weiss G. B. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J Pharmacol Exp Ther. 1968 Jan;159(1):91–97. [PubMed] [Google Scholar]
  14. Keaney J. F., Jr, Xu A., Cunningham D., Jackson T., Frei B., Vita J. A. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest. 1995 Jun;95(6):2520–2529. doi: 10.1172/JCI117953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Khalil R., Lodge N., Saida K., van Breemen C. Mechanism of calcium activation in vascular smooth muscle. J Hypertens Suppl. 1987 Dec;5(4):S5–15. doi: 10.1097/00004872-198712004-00003. [DOI] [PubMed] [Google Scholar]
  16. Kolodgie F. D., Virmani R., Rice H. E., Mergner W. J. Vascular reactivity during the progression of atherosclerotic plaque. A study in Watanabe heritable hyperlipidemic rabbits. Circ Res. 1990 Apr;66(4):1112–1126. doi: 10.1161/01.res.66.4.1112. [DOI] [PubMed] [Google Scholar]
  17. Korn S. J., Horn R. Nordihydroguaiaretic acid inhibits voltage-activated Ca2+ currents independently of lipoxygenase inhibition. Mol Pharmacol. 1990 Oct;38(4):524–530. [PubMed] [Google Scholar]
  18. Kugiyama K., Kerns S. A., Morrisett J. D., Roberts R., Henry P. D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990 Mar 8;344(6262):160–162. doi: 10.1038/344160a0. [DOI] [PubMed] [Google Scholar]
  19. Kugiyama K., Kerns S. A., Morrisett J. D., Roberts R., Henry P. D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990 Mar 8;344(6262):160–162. doi: 10.1038/344160a0. [DOI] [PubMed] [Google Scholar]
  20. Leijten P. A., van Breemen C. The effects of caffeine on the noradrenaline-sensitive calcium store in rabbit aorta. J Physiol. 1984 Dec;357:327–339. doi: 10.1113/jphysiol.1984.sp015502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lichtlen P. R., Hugenholtz P. G., Rafflenbeul W., Hecker H., Jost S., Deckers J. W. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators. Lancet. 1990 May 12;335(8698):1109–1113. doi: 10.1016/0140-6736(90)91121-p. [DOI] [PubMed] [Google Scholar]
  22. Meisheri K. D., Hwang O., van Breemen C. Evidence for two separated Ca2+ pathways in smooth muscle plasmalemma. J Membr Biol. 1981 Mar 15;59(1):19–25. doi: 10.1007/BF01870817. [DOI] [PubMed] [Google Scholar]
  23. Parthasarathy S., Young S. G., Witztum J. L., Pittman R. C., Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest. 1986 Feb;77(2):641–644. doi: 10.1172/JCI112349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pfeuffer M. A., Richard B. M., Pittman R. C. Probucol increases the selective uptake of HDL cholesterol esters by Hep G2 human hepatoma cells. Arterioscler Thromb. 1992 Jul;12(7):870–878. doi: 10.1161/01.atv.12.7.870. [DOI] [PubMed] [Google Scholar]
  25. Plane F., Jacobs M., McManus D., Bruckdorfer K. R. Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins. Atherosclerosis. 1993 Oct;103(1):73–79. doi: 10.1016/0021-9150(93)90041-r. [DOI] [PubMed] [Google Scholar]
  26. Saso Y., Kitamura K., Yasoshima A., Iwasaki H. O., Takashima K., Doi K., Morita T. Rapid induction of atherosclerosis in rabbits. Histol Histopathol. 1992 Jul;7(3):315–320. [PubMed] [Google Scholar]
  27. Sgaragli G. P., Valoti M., Gorelli B., Fusi F., Palmi M., Mantovani P. Calcium antagonist and antiperoxidant properties of some hindered phenols. Br J Pharmacol. 1993 Sep;110(1):369–377. doi: 10.1111/j.1476-5381.1993.tb13819.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sigurdsson S. B., Uvelius B., Johansson B. Relative contribution of superficially bound and extracellular calcium to activation of contraction in isolated rat portal vein. Acta Physiol Scand. 1975 Nov;95(3):263–269. doi: 10.1111/j.1748-1716.1975.tb10050.x. [DOI] [PubMed] [Google Scholar]
  29. Simon B. C., Haudenschild C. C., Cohen R. A. Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J Cardiovasc Pharmacol. 1993 Jun;21(6):893–901. doi: 10.1097/00005344-199306000-00007. [DOI] [PubMed] [Google Scholar]
  30. Stary H. C. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J. 1990 Aug;11 (Suppl E):3–19. doi: 10.1093/eurheartj/11.suppl_e.3. [DOI] [PubMed] [Google Scholar]
  31. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. doi: 10.1056/NEJM198904063201407. [DOI] [PubMed] [Google Scholar]
  32. Steinberg D., Witztum J. L. Lipoproteins and atherogenesis. Current concepts. JAMA. 1990 Dec 19;264(23):3047–3052. [PubMed] [Google Scholar]
  33. Tejerina T., Cauvin C., Tamargo J. Effects of oxodipine on isolated rabbit aorta and mesenteric resistance vessels. Eur J Pharmacol. 1992 Aug 25;219(2):279–284. doi: 10.1016/0014-2999(92)90306-o. [DOI] [PubMed] [Google Scholar]
  34. Tejerina T., Sesin J., Delgado C., Tamargo J. Effect of milrinone on contractility and 45Ca movements in the isolated rabbit aorta. Eur J Pharmacol. 1988 Mar 29;148(2):239–246. doi: 10.1016/0014-2999(88)90569-9. [DOI] [PubMed] [Google Scholar]
  35. Ubeda A., Tejerina T., Tamargo J., Villar A. Effects of khellin on contractile responses and 45Ca2+ movements in rat isolated aorta. J Pharm Pharmacol. 1991 Jan;43(1):46–48. doi: 10.1111/j.2042-7158.1991.tb05447.x. [DOI] [PubMed] [Google Scholar]
  36. Van Hinsbergh V. W. LDL cytotoxicity. The state of the art. Atherosclerosis. 1984 Nov;53(2):113–118. doi: 10.1016/0021-9150(84)90188-6. [DOI] [PubMed] [Google Scholar]
  37. Watanabe N., Ishikawa Y., Okamoto R., Watanabe Y., Fukuzaki H. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits. Artery. 1987;14(5):283–294. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES